Name: Hiv (en Inglés)
SKU: 62923507
Price: 32.05 USD
Availability: InStock
Author: Leon Freytag; Liam Kelley

Formato

Libro Físico

Editorial

Grin Verlag

Autor

Leon Freytag; Liam Kelley

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

ISBN13

9783668215436

Hiv (en Inglés)

Leon Freytag; Liam Kelley (Autor) · Grin Verlag · Tapa Blanda

Libro Nuevo Importado

Envío: 25 a 32 días háb.

$ 64.11$ 32.05

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 32.05

Llega entre el 02 Oct y el 16 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Hiv (en Inglés)"

Seminar paper from the year 2016 in the subject Sociology - Medical Care, grade: 1,0, language: English, abstract: This essay will provide a basis for a thick description of the AIDS issue in France. We describe the history of politics surrounding AIDS, the conception of Public Health in France, French ideologies and the relationship to stigma and language. All of these are of particular salience when addressing an issue like AIDS, which is a non-linear issue in that it cannot be attributed to any one cause. France has the highest number of HIV-positives in all Europe. The number of people living with HIV/AIDS in France has steadily increased in the last decade from 120,000 in 2005 to about 150.000 in 2015 (indexmundi, 2015). Its prevalence rate, 0.4%, is also relatively high compared to the rest of Europe, e.g. 0.2% in the UK and 0.1% in Germany. Every year between 1500-2000 people die of HIV/AIDS in France (Ibid). This is only about 1% of the total number of HIV-positives, showing that France does reasonably well in providing ART (anti-retroviral treatment). Rather they have been facing difficulties regarding prevention. The rate of newly diagnosed HIV infections has been decreasing, but only slowly, from 9.5 per 100 000 in 2005 to 6.3 per 100 000 in 2011 (WHO, 2011). It is striking that more than a third of seropositives remain undiagnosed in France (Supervie et al., 2014).